|
|
||||||||
1 Gazes Cardiac Research Institute, Medical University of South Carolina, and Department of Veterans Affairs Medical Center, Charleston, South Carolina 29403; and 2 Cardiology Division, Department of Medicine, Duke University Medical Center and Department of Veterans Affairs Medical Center, Durham, North Carolina 27705
| |
ABSTRACT |
|---|
|
|
|---|
Severe left ventricular volume overloading causes myocardial and cellular contractile dysfunction. Whether this is also true for severe right ventricular volume overloading was unknown. We therefore created severe tricuspid regurgitation percutaneously in seven dogs and then observed them for 3.5-4.0 yr. All five surviving operated dogs had severe tricuspid regurgitation and right heart failure, including massive ascites, but they did not have left heart failure. Right ventricular cardiocytes were isolated from these and from normal dogs, and sarcomere mechanics were assessed via laser diffraction. Right ventricular cardiocytes from the tricuspid regurgitation dogs were 20% longer than control cells, but neither the extent (0.171 ± 0.005 µm) nor the velocity (2.92 ± 0.12 µm/s) of sarcomere shortening differed from controls (0.179 ± 0.005 µm and 3.09 ± 0.11 µm/s, respectively). Thus, despite massive tricuspid regurgitation causing overt right heart failure, intrinsic right ventricular contractile function was normal. This finding for the severely volume-overloaded right ventricle stands in distinct contrast to our finding for the left ventricle severely volume overloaded by mitral regurgitation, wherein intrinsic contractile function is depressed.
mitral regurgitation; cardiocyte contractile function
| |
INTRODUCTION |
|---|
|
|
|---|
PATHOLOGICAL VENTRICULAR VOLUME OVERLOADING is caused by a variety of structural and metabolic abnormalities. Experimental models of pathological left ventricular (LV) volume overloading have shown that, as in humans, if not initially lethal it may be tolerated for an extended period of time, but left heart failure develops eventually if a sustained volume overload is severe. In mitral regurgitation, this is based on muscle dysfunction at the level of the ventricle and of its constituent cardiocytes (29), which in turn appears to be caused by myofibrillar lysis (29), abnormalities of the force-frequency relationship, and calcium metabolism (2, 18).
Right ventricular (RV) volume overloading appears to be better tolerated than LV volume overloading. We have found, for instance, that experimental animals with severe RV volume overloading caused by atrial septal resection, which results in a ratio of pulmonary to systemic blood flow as great as 4:1, exhibit normal RV muscle function and energetics for at least 6 mo (8). Furthermore, humans with similarly severe RV volume overloading caused by atrial septal defects exhibit normal RV systolic function indefinitely if pulmonary hypertension with consequent RV pressure overloading does not supervene (16). However, because the geometry of the RV makes separation of loading conditions from intrinsic contractility difficult and because the calculations of wall stress often used to estimate RV loading are extremely complex and remain largely unvalidated, intrinsic RV contractility has been difficult to assess (20, 23).
Over the past decade, we have shown that, for both normal and abnormal myocardium, the contractile function of isolated cardiocytes assessed in vitro mirrors the intrinsic contractile function in vivo of the ventricle from which the cardiocytes were isolated (15, 29). We therefore used this principle here to test the hypothesis that intrinsic contractile function is normal in long-term, severe RV volume overloading.
| |
METHODS |
|---|
|
|
|---|
Animal models.
Mongrel dogs of random sex weighing 25-35 kg were the subjects of
this study. For the creation of tricuspid regurgitation, anesthesia in
dogs sedated with morphine was induced with thiopental sodium (15 ml
iv). After intubation, we maintained anesthesia by inhalation
of halothane (5% initially, followed by 0.2-0.5%). All
procedures and the care of the dogs were in accordance with institutional guidelines, which meet or exceed those of the American Physiological Society and the American Association for Accreditation of
Laboratory Animal Care. Tricuspid regurgitation was created in seven
dogs by a modification (1, 10) of the closed-chest, catheter-based method that we use for creating mitral regurgitation (3, 29). Of note, in contrast to the transient hemodynamic instability often seen after surgically created mitral regurgitation (29), this did not occur after surgically created
tricuspid regurgitation. Seven normal dogs served as controls. After
recovery, we maintained each operated dog on a standard canine diet for 3.5-4.0 yr. Two operated dogs experienced unobserved sudden death at the end of the study period. At final study, each remaining dog was
lightly anesthetized with intravenous fentanyl-droperidol and inhaled
nitrous oxide-oxygen, a combination having little effect on myocardial
contractile function (29). To prevent the confounding
influences of changing adrenergic tone on inotropic state and heart
rate during estimations of contractility, measurements of ventricular
function were made in a
-blocked state, as validated by
isoproterenol challenge (29), induced by a loading dose of esmolol (0.5 mg · kg
1 · min
1
iv for 3 min) followed by a constant infusion of esmolol (0.3 mg · kg
1 · min
1 iv).
Sheaths for arterial and venous access were placed in the femoral
region, and systemic arterial pressures were monitored. After measuring
right-sided pressures with a Swan-Ganz catheter, we performed left and
right ventriculography with the use of a pigtail catheter for the LV
and a Nishiya catheter (22) for the RV. These procedures
for evaluating ventricular function were based on those used before in
evaluating our model of surgically created mitral regurgitation
(3, 29).
Cardiocyte isolation. Immediately after the in vivo evaluation of cardiac function by one subset of investigators, and after the dogs were more deeply anesthetized, another subset of investigators, who were not informed of the results of this evaluation, isolated and evaluated cardiocytes from these same RVs as follows. A right lateral thoracotomy was performed, the pericardium was excised, and the right coronary artery was isolated. The heart was removed and placed in cold, nominally calcium-free buffer of the following composition (in mM): 13.0 NaCl, 4.8 KCl, 1.2 MgSO4, 1.2 NaH2PO4, 2.5 NaHCO3, 12.0 HEPES buffer, and 12.5 glucose; 6 mg/l insulin was also added. The right coronary artery was cannulated immediately, and perfusion with the same buffer was initiated. The RV free wall was removed from the rest of the heart, and the specimen was cleared of blood by brief perfusion with the same buffer warmed to 37°C and gassed with 100% O2. The method then used to dissociate cardiocytes from the canine RV was modified from that previously reported by us for the canine LV (29): perfusion was continued for 25 min at 37°C by recirculating the buffer, now supplemented with 155 U/ml type II collagenase and 10 µM Ca2+; mean pressure (~90 mmHg) and pH (~7.40) were kept within the physiological range. Any undissociated tissue was discarded and that remaining was placed in a chamber containing the above buffer supplemented with 0.3 mM Ca2+, 2.5% bovine serum albumin, and 62 U/ml of the same collagenase used for perfusion. After mincing the tissue into small pieces with scissors, we gently agitated the tissue for 5 min at 37°C in the same buffer while gassing the tissue with 100% oxygen. Dissociated cardiocytes were harvested by passing the supernatant through a 210-µm nylon mesh and collecting them by gravity. The Ca2+ concentration was gradually increased to 2.5 mM, after which the cells were kept for 1 h at 37°C in collagenase-free buffer before defining contractile function.
Cardiocyte mechanics.
Our methods for laser diffraction measurement of sarcomere motion in
isolated cardiocytes have been described before (15, 29).
Cells were added to 37°C, 2.5 mM Ca2+ buffer in a well
affixed to a glass slide. Only single, rod-shaped cells with a resting
sarcomere length
1.85 µm and that contracted with each stimulus and
were quiescent between stimuli were analyzed. Ten steady-state
contractions during 0.25-Hz electrical stimulation were sampled and
averaged to yield a final profile of sarcomere length and velocity
versus time during contraction. Changes in sarcomere length were
measured at a sampling rate of 1 kHz from movement of the first-order
diffraction pattern cast by light from a substage helium-neon laser
passing through the sarcomeres.
Cardiocyte morphology. Two aliquots of isolated cardiocytes from each specimen were plated in separate dishes, and randomly selected cell images were captured on an inverted microscope at a magnification of ×400 by a frame grabber. The images were printed at a final magnification of ×1,100, and cell length and width were measured manually.
Statistical analysis. The mean value and the standard error of the mean are shown for each group of data. Differences in selected measures were evaluated via an unpaired Student's t-test, with a significant difference said to exist at the level specified in each case.
| |
RESULTS |
|---|
|
|
|---|
Characteristics of experimental model.
All of the dogs with tricuspid regurgitation had, on physical
examination, a grade III-IV/VI pansystolic murmur at the lower left sternal border, with a readily palpable parasternal thrill. Right
heart failure, as evidenced by marked peripheral edema and ascites, was
prominent in all dogs. As shown in Table
1, RV systolic pressure was normal, as
was aortic systolic pressure. Right ventriculography, shown in Fig.
1, demonstrated in each dog with
tricuspid regurgitation complete and rapid opacification of the right
atrium at end systole, and there was incomplete ejection of contrast
material from the right atrium at end diastole. Thus isolated, severe
RV volume overloading causing overt right heart failure was present in
each of these dogs.
|
|
Cardiocyte morphology.
Cardiocyte dimensions were evaluated in terms of cellular length and
width. As given numerically in Table 2
and illustrated in Fig. 2, RV
cardiocytes from the dogs with tricuspid regurgitation were
significantly longer and wider than RV cardiocytes from control dogs.
Both the numerical values from and the appearance of volume-overloaded hypertrophied RV cells here are strikingly similar to those found in
our previous study (see Ref. 29; Table 4 and Fig. 3) of
volume-overloaded hypertrophied LV cells from dogs with isolated,
severe mitral regurgitation.
|
|
Cardiocyte mechanics.
Representative illustrations of sarcomere mechanics in cardiocytes from
control and tricuspid regurgitation RVs are shown in Fig.
3. Because our intent in this study was
to compare intrinsic myocardial contractile function in RV volume
overloading caused by tricuspid regurgitation with that in LV volume
overloading caused by mitral regurgitation, illustrative sarcomere
mechanics from our study (29) of cardiocytes from control
and mitral regurgitation LVs are also shown in Fig. 3. Summary data in
Fig. 4 show that the extent and velocity
of sarcomere shortening in RV cardiocytes from dogs with tricuspid
regurgitation were only slightly decreased when compared with
corresponding values for cells from control dogs, with no statistical
difference; there was no significant difference between control versus
tricuspid regurgitation cardiocytes in terms of initial sarcomere
length (1.941 ± 0.011 vs. 1.918 ± 0.009 µm), time to peak
shortening (214 ± 2 vs. 215 ± 2 ms), peak relaxation
velocity (3.90 ± 0.14 vs. 3.63 ± 0.17 µm/s), or time to
peak relaxation velocity (39 ± 2 vs. 42 ± 1 ms). However, as shown for comparison purposes in Fig. 4, LV cardiocytes from dogs
with severe mitral regurgitation (29), albeit at a
different temporal but at a similar pathophysiological point in the
progression of heart failure, showed significant decrements both in the
extent and in the velocity of sarcomere shortening.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The principal finding of this study is that the contractile function intrinsic to the RV of dogs with long-standing, severe RV volume overloading is normal. This stands in distinct contrast to our earlier studies of severe LV volume overloading, wherein intrinsic contractile function was depressed (19, 27, 29). This contrast is all the more striking when one considers that the dogs with severe mitral regurgitation were studied at 3-6 mo after the lesion was produced, whereas the dogs with severe tricuspid regurgitation were studied at 3.5-4.0 yr after the lesion was produced. Indeed, we would have preferred to have more dogs available here for final study, but the fact that contractile function was normal in tricuspid regurgitation gives us confidence in the validity of our principal finding. That is, experimental artifacts exaggerated by a low sample number might well have led to a false finding of abnormal function, but artifactual contributions to a finding of normal function are much less likely.
The distinction made evident through the striking difference between the present study of RV volume overloading by tricuspid regurgitation and the previous studies (19, 27, 29) of LV volume overloading by mitral regurgitation is that between muscle failure versus pump failure as the root cause of the congestive heart failure syndrome. In the present study of tricuspid regurgitation, all of the dogs had severe, clinically overt right-sided congestive heart failure, with ascites and loss of appetite. Indeed, two of the original operative cohort experienced sudden death, which triggered the final study of the remaining dogs. While it is likely that these dogs experienced a lethal arrythmia, because they were not being monitored electrocardiographically this cannot be known with certainty. But most significantly, the root cause of congestive heart failure in these dogs is shown here to be pump rather than muscle failure. In the previous study of mitral regurgitation, all of the dogs by 6 mo after the operation had clinically overt, rapidly progressive left-sided congestive heart failure that precluded longer-term study. But in contrast to the situation in the present study, the root cause of congestive heart failure in mitral regurgitation was shown to be muscle rather than pump failure.
The principal value of this study, therefore, is the evidence provided that even with the prolonged and extreme degree of hemodynamic overloading imposed here, the cardiac hypertrophy that results is not necessarily maladaptive, in that normal cellular contractile function may be retained. That is, it is not solely the magnitude but equally the type of hemodynamic overloading that determines whether the cardiac hypertrophic response to any such challenge remains compensatory. Nor can the difference between the RV and LV functional response to volume overloading be attributed to intrinsic differences between RV and LV cardiocytes, because we have shown that the functional responses of cardiocytes from the two chambers to biventricular volume overloading is identical (28). Rather, the differing myocardial responses to these two volume overloads may well relate to the established role of hemodynamic load in regulating cardiac mass (6, 7). That is, load in the form of systolic afterload immediately after major atrioventricular valvular incompetence is imposed may be relatively better preserved in the lower pressure RV with tricuspid regurgitation than it is in the higher pressure LV with mitral regurgitation. The consequence of this loading difference in terms of stimulating cardiac hypertrophy may be aggravated by the fact that there is a diminished LV hypertrophic load response during mitral regurgitation to a given amount of stroke work input (5). Furthermore, because by Laplace's law ventricular wall stress is related to the product of intraventricular pressure and ventricular radius and because RV chamber compliance is very high, an increase in ventricular radius and a subsequent increase in wall stress may induce a more effective hypertrophic response in tricuspid than in mitral regurgitation. Thus the attenuated LV hypertrophic response to load in mitral regurgitation may lead by default to an early, sustained reliance on increases in heart rate and adrenergic tone, which we have shown to be clearly deleterious to intrinsic myocardial properties in mitral regurgitation (19, 27) and to intrinsic cardiac cellular properties in normal isolated cardiocytes (17).
This difference between RV and LV volume overloading may also be related, at least speculatively, to the following additional factors. First, the initial hemodynamic burden caused by sudden and severe atrioventricular valvular incompetence may be greater when imposed on the high-systolic-pressure LV than it is when imposed on the low-systolic-pressure RV. Second, in the present study of tricuspid regurgitation, LV function was normal, such that there may have been less neurohumoral stimulation (12). The renin-angiotensin system and sympathetic nervous system have a clear role in the development of LV failure after systemic hemodynamic overloads (14), but these systems could be less important in isolated tricuspid regurgitation in the absence of LV dysfunction. Third, because LV contraction contributes to the generation of RV stroke work via the interventricular septum (13, 23), the normal interventricular septum in tricuspid regurgitation may contribute to the maintenance of overall RV function.
Clinical experience demonstrates that RV volume overloading is well tolerated in the absence of pressure overloading superimposed by pulmonary hypertension (16, 20). Furthermore, experimental animal models of arterio-venous fistula (24, 28), atrio-ventricular blockade (21), and atrial septal defect (8) also demonstrate normal intrinsic RV function in RV volume overloading. In contrast, whereas chronic LV volume overloading in humans may be tolerated for years, LV dysfunction and heart failure often supervene eventually (4, 9, 11, 25, 26), quite possibly related to our finding of depressed intrinsic LV contractile function in this entity (29). Thus, whereas both RV and LV volume overloading may cause overt heart failure, the preserved intrinsic RV contractile function shown in this and in our earlier study (8) of RV volume overloading, and the exhausted intrinsic LV contractile function shown in our studies (3, 5, 19, 27, 29) of LV volume overloading, suggest that the etiology of this heart failure may be predominantly nonmyocardial in the former case and myocardial in the latter case.
| |
ACKNOWLEDGEMENTS |
|---|
The authors thank Dr. Robert Bauman for preparing the dogs with tricuspid regurgitation as well as Gilberto DeFreyte and Mary Barnes for technical assistance.
| |
FOOTNOTES |
|---|
This study was supported by National Heart, Lung, and Blood Institute Grants HL-18468 and HL-48788 and by research funds from the Department of Veterans Affairs.
Address for reprint requests and other correspondence: G. Cooper, IV, Gazes Cardiac Research Institute, P.O. Box 250773, Medical Univ. of South Carolina, 114 Doughty St., Charleston, SC 29403 (E-mail: cooperge{at}musc.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 9 February 2000; accepted in final form 1 August 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Bauman, RP,
Rembert JC,
and
Greenfield JC, Jr.
Myocardial blood flow in awake dogs with chronic tricuspid regurgitation.
Basic Res Cardiol
93:
63-69,
1998[ISI][Medline].
2.
Bonz, A,
Vahl CF,
and
Hagl S.
Contractile behaviour and intracellular calcium during afterloaded contraction in mitral valve disease.
Thorac Cardiovasc Surg
45:
280-286,
1997[ISI][Medline].
3.
Carabello, BA,
Nakano K,
Corin W,
Biederman R,
and
Spann JF, Jr.
Left ventricular function in experimental volume overload hypertrophy.
Am J Physiol Heart Circ Physiol
256:
H974-H981,
1989
4.
Carabello, BA,
Nolan SP,
and
McGuire LB.
Assessment of preoperative left ventricular function in patients with mitral regurgitation: value of the end-systolic wall stress-end-systolic volume ratio.
Circulation
64:
1212-1217,
1981
5.
Carabello, BA,
Zile MR,
Tanaka R,
and
Cooper G.
Left ventricular hypertrophy due to volume overload versus pressure overload.
Am J Physiol Heart Circ Physiol
263:
H1137-H1144,
1992
6.
Cooper, G.
Cardiocyte adaptation to chronically altered load.
Annu Rev Physiol
49:
501-518,
1987[ISI][Medline].
7.
Cooper, G.
Basic mechanisms of myocardial hypertrophy: a review of molecular mechanisms.
Annu Rev Med
48:
13-23,
1997[ISI][Medline].
8.
Cooper, G,
Puga FJ,
Zujko KJ,
Harrison CE,
and
Coleman HN.
Normal myocardial function and energetics in volume-overload hypertrophy in the cat.
Circ Res
32:
140-148,
1973
9.
Corin, WJ,
Monrad ES,
Murakami T,
Nonogi H,
Hess OM,
and
Krayenbuehl HP.
The relationship of afterload to ejection performance in chronic mitral regurgitation.
Circulation
76:
59-67,
1987
10.
Dolber, PC,
Bauman RP,
Rembert JC,
and
Greenfield JC, Jr.
Regional changes in myocyte structure in model of canine right atrial hypertrophy.
Am J Physiol Heart Circ Physiol
267:
H1279-H1287,
1994
11.
Eckberg, DL,
Gault JH,
Bouchard RL,
Karliner JS,
and
Ross J, Jr.
Mechanics of left ventricular contraction in chronic severe mitral regurgitation.
Circulation
47:
1252-1259,
1973
12.
Francis, GS,
Benedict C,
Johnstone DE,
Kirlin PC,
Nicklas J,
Liang CS,
Kubo SH,
Rudin-Toretsky E,
and
Yusuf S.
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
Circulation
82:
1724-1729,
1990
13.
Hoffman, D,
Sisto D,
Frater RW,
and
Nikolic SD.
Left-to-right ventricular interaction with a noncontracting right ventricle.
J Thorac Cardiovasc Surg
107:
1496-1502,
1994
14.
Katz, AM.
Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure.
N Engl J Med
322:
100-110,
1990[ISI][Medline].
15.
Kent, RL,
Mann DL,
Urabe Y,
Hisano R,
Hewett KW,
Loughnane M,
and
Cooper G.
Contractile function of isolated feline cardiocytes in response to viscous loading.
Am J Physiol Heart Circ Physiol
257:
H1717-H1727,
1989
16.
Liberthson, RR,
Boucher CA,
Strauss HW,
Dinsmore RE,
McKusick KA,
and
Pohost GM.
Right ventricular function in adult atrial septal defect. Preoperative and postoperative assessment and clinical implications.
Am J Cardiol
47:
56-60,
1981[ISI][Medline].
17.
Mann, DL,
Kent RL,
Parsons B,
and
Cooper G.
Adrenergic effects on the biology of the adult mammalian cardiocyte.
Circulation
85:
790-804,
1992
18.
Mulieri, LA,
Leavitt BJ,
Martin BJ,
Haeberle JR,
and
Alpert NR.
Myocardial force-frequency defect in mitral regurgitation heart failure is reversed by forskolin.
Circulation
88:
2700-2704,
1993
19.
Nagatsu, M,
Spinale FG,
Koide M,
Tagawa H,
DeFreitas G,
Cooper G,
and
Carabello BA.
Bradycardia and the role of
-blockade in the amelioration of left ventricular dysfunction.
Circulation
101:
653-659,
2000
20.
Nagel, E,
Stuber M,
and
Hess OM.
Importance of the right ventricle in valvular heart disease.
Eur Heart J
17:
829-836,
1996
21.
Newman, WH.
Contractile state of hypertrophied left ventricle in long-standing volume overload.
Am J Physiol Heart Circ Physiol
234:
H88-H93,
1978.
22.
Nishiya, Y,
Imamura E,
and
Inoue Y.
A new preshaped catheter for right ventriculography with minimal artificial tricuspid regurgitation.
Ann Thorac Cardiovasc Surg
4:
214-216,
1998[Medline].
23.
Rigolin, VH,
Robiolio PA,
Wilson JS,
Harrison JK,
and
Bashore TM.
The forgotten chamber: the importance of the right ventricle.
Cathet Cardiovasc Diagn
35:
18-28,
1995[ISI][Medline].
24.
Ross, J, Jr,
and
McCullagh WH.
Nature of enhanced performance of the dilated left ventricle in the dog during chronic volume overloading.
Circ Res
30:
549-556,
1972
25.
Schuler, G,
Peterson KL,
Johnson A,
Francis G,
Dennish G,
Utley J,
Daily PO,
Ashburn W,
and
Ross J, Jr.
Temporal response of left ventricular performance to mitral valve surgery.
Circulation
59:
1218-1231,
1979
26.
Starling, MR,
Kirsh MM,
Montgomery DG,
and
Gross MD.
Impaired left ventricular contractile function in patients with long-term mitral regurgitation and normal ejection fraction.
J Am Coll Cardiol
22:
239-250,
1993[Abstract].
27.
Tsutsui, H,
Spinale FG,
Nagatsu M,
Schmid PG,
Ishihara K,
DeFreyte G,
Cooper G,
and
Carabello BA.
Effects of chronic
-adrenergic blockade on the left ventricular and cardiocyte abnormalities in chronic canine mitral regurgitation.
J Clin Invest
93:
2639-2648,
1994.
28.
Urabe, Y,
Hamada Y,
Spinale FG,
Carabello BA,
Kent RL,
Cooper G,
and
Mann DL.
Cardiocyte contractile performance in experimental biventricular volume-overload hypertrophy.
Am J Physiol Heart Circ Physiol
264:
H1615-H1623,
1993
29.
Urabe, Y,
Mann DL,
Kent RL,
Nakano K,
Tomanek RJ,
Carabello BA,
and
Cooper G.
Cellular and ventricular contractile dysfunction in experimental canine mitral regurgitation.
Circ Res
70:
131-147,
1992
This article has been cited by other articles:
![]() |
G. Cooper IV Cytoskeletal networks and the regulation of cardiac contractility: microtubules, hypertrophy, and cardiac dysfunction Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1003 - H1014. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |